botulinum antibody therapy (Emergent/HPA)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namebotulinum antibody therapy (Emergent/HPA)
Drug Alias Namebotulinum immune globin (Emergent/HPA)botulism immunoglobulin therapy (Emergent/HPA)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodies
Mechanisms of ActionBotulinum toxin inhibitors
TargetsBotulinum toxin
Therapy Area/IndicationsBotulism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEmergent Biosolutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHealth Protection AgencyEmergent Biosolutions Inc
Active IndicationsN/A
Inactive IndicationsBotulism

Other Information

ATC CodeN/A
Related LinksN/A